Clinical Trial Update: Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing safety and efficacy of RAAS therapy alone or with spironolactone in chronic renal insufficiency and diabetic nephropathy type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Renal Failure

Drugs mentioned

• RAAS therapy
• Spironolactone (spironolactone)

Snippet

Sponsor: James A. Tumlin, MD | Conditions: Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 | Phase 4 | Status: UNKNOWN